Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome vs ropivacaine for acute pain after hemorrhoidectomy
ChiCTR2400094525Phase 4Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in hemorrhoid and postoperative pain (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Area under the curve of pain intensity score on numerical rating scale (NRS). Started Dec 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
hemorrhoidpostoperative pain
Beyond the preview
Go deeper on ChiCTR2400094525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094525.